GB9007569D0 - Carbo-nucleoside derivatives - Google Patents

Carbo-nucleoside derivatives

Info

Publication number
GB9007569D0
GB9007569D0 GB909007569A GB9007569A GB9007569D0 GB 9007569 D0 GB9007569 D0 GB 9007569D0 GB 909007569 A GB909007569 A GB 909007569A GB 9007569 A GB9007569 A GB 9007569A GB 9007569 D0 GB9007569 D0 GB 9007569D0
Authority
GB
United Kingdom
Prior art keywords
carbo
nucleoside derivatives
nucleoside
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909007569A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed AS filed Critical Nycomed AS
Priority to GB909007569A priority Critical patent/GB9007569D0/en
Publication of GB9007569D0 publication Critical patent/GB9007569D0/en
Priority to JP91507691A priority patent/JPH05507267A/en
Priority to CA002079815A priority patent/CA2079815A1/en
Priority to EP91907828A priority patent/EP0523160A1/en
Priority to PCT/EP1991/000655 priority patent/WO1991015488A1/en
Priority to AU76959/91A priority patent/AU7695991A/en
Priority to OA60272A priority patent/OA09670A/en
Priority to NO92923848A priority patent/NO923848L/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
GB909007569A 1990-04-04 1990-04-04 Carbo-nucleoside derivatives Pending GB9007569D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB909007569A GB9007569D0 (en) 1990-04-04 1990-04-04 Carbo-nucleoside derivatives
JP91507691A JPH05507267A (en) 1990-04-04 1991-04-04 Carbonucleoside derivatives
CA002079815A CA2079815A1 (en) 1990-04-04 1991-04-04 Carbo-nucleoside derivatives
EP91907828A EP0523160A1 (en) 1990-04-04 1991-04-04 Carbo-nucleoside derivatives
PCT/EP1991/000655 WO1991015488A1 (en) 1990-04-04 1991-04-04 Carbo-nucleoside derivatives
AU76959/91A AU7695991A (en) 1990-04-04 1991-04-04 Carbo-nucleoside derivatives
OA60272A OA09670A (en) 1990-04-04 1992-09-11 Carbo-nucleoside derivatives
NO92923848A NO923848L (en) 1990-04-04 1992-10-02 KARBO-nucleoside derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007569A GB9007569D0 (en) 1990-04-04 1990-04-04 Carbo-nucleoside derivatives

Publications (1)

Publication Number Publication Date
GB9007569D0 true GB9007569D0 (en) 1990-05-30

Family

ID=10673843

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909007569A Pending GB9007569D0 (en) 1990-04-04 1990-04-04 Carbo-nucleoside derivatives

Country Status (7)

Country Link
EP (1) EP0523160A1 (en)
JP (1) JPH05507267A (en)
AU (1) AU7695991A (en)
CA (1) CA2079815A1 (en)
GB (1) GB9007569D0 (en)
OA (1) OA09670A (en)
WO (1) WO1991015488A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0630897A3 (en) * 1993-06-25 1995-03-01 Bristol Myers Squibb Co 3-Hydroxy-4-hydroxymethyl-2-methylene-cyclopentyl purines and pyrimidines.
IL138037A0 (en) * 1998-02-25 2001-10-31 Univ Emory 2'-fluoronucleosides
DE60011787T2 (en) * 1999-09-10 2005-07-14 Stichting Rega V.Z.W. CARBOCYCLIC NUCLEOSIDES AND PROCESS FOR THEIR PREPARATION
CN1646141B (en) 2000-10-18 2014-06-25 吉利德制药有限责任公司 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
CA2463719A1 (en) 2003-04-05 2004-10-05 F. Hoffmann-La Roche Ag Nucleotide analogs with six membered rings
MX2010000424A (en) * 2007-07-09 2010-08-10 Easter Virginia Medical School Substituted nucleoside derivatives with antiviral and antimicrobial properties.
CA2766033C (en) 2009-06-25 2016-09-20 Alkermes, Inc. Prodrugs of nh-acidic compounds
CA3092335A1 (en) 2018-03-05 2019-09-12 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU542271B2 (en) * 1980-06-23 1985-02-14 Regents Of The University Of Minnesota Adenine nucleosides
US4396623A (en) * 1981-08-26 1983-08-02 Southern Research Institute Carbocyclic analogs of uracil nucleosides as antiviral agents
US4719214A (en) * 1985-07-25 1988-01-12 Southern Research Institute Carbocyclic analogues of thymine nucleosides
AU613026B2 (en) * 1987-03-24 1991-07-25 Nycomed As 2',3' dideoxyribofuranoxide derivatives
US5015739A (en) * 1988-04-22 1991-05-14 Schering Corporation Processes for preparation of cyclopentyl purine derivatives

Also Published As

Publication number Publication date
WO1991015488A1 (en) 1991-10-17
OA09670A (en) 1993-05-15
JPH05507267A (en) 1993-10-21
CA2079815A1 (en) 1991-10-05
AU7695991A (en) 1991-10-30
EP0523160A1 (en) 1993-01-20

Similar Documents

Publication Publication Date Title
EP0440950A3 (en) Halogenallyl-azolyl derivatives
HU912356D0 (en) Rapacmycine derivatives
ZA916098B (en) Oxazolidinodione derivatives
EP0470466A3 (en) Halogenalkyl-azolyl derivatives
ZA914484B (en) Azolyl-propanol derivatives
ZA9172B (en) Azaoxindole derivatives
HRP930485A2 (en) Hiv-inhibiting benzenacetamide derivatives
IL99576A0 (en) Triazacyclohexane derivatives
EP0438690A3 (en) Substituted pyrazolin derivatives
ZA916254B (en) Halogenoalkyl-azolyl derivatives
EP0485984A3 (en) Diarylmethoxypiperidine derivatives
ZA914204B (en) Pyridinylpiperazine derivatives
EP0520435A3 (en) Dc-89 derivatives
OA09670A (en) Carbo-nucleoside derivatives
EP0440949A3 (en) Halogenallyl-azolyl derivatives
ZA914675B (en) 5-isothiazolamine derivatives
EP0453883A3 (en) 2-amino-4-trichloropyridine derivatives
AP9100308A0 (en) Carboxymethylcyclopropane derivatives
GB2249094B (en) Hetero-imidazodiazepine derivatives
EP0449346A3 (en) 4-piperidinyl-ergoline derivatives
EG19474A (en) Nitroenamine derivatives
EG19362A (en) Azoaxindole derivatives
ZA914073B (en) Dioxo-tetrahydroquinoline derivatives
IE901471L (en) Phodomycin derivatives
HU9202568D0 (en) 3-piperidino-4-hydroxi-chromane derivatives